Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2017, Article ID 2345617, 9 pages
https://doi.org/10.1155/2017/2345617
Review Article

Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review

1Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA
2School of Public Health, American University of Armenia, Yerevan, Armenia

Correspondence should be addressed to Hacsi Horvath; moc.liamg@htavroh.iscah

Received 10 May 2017; Accepted 16 July 2017; Published 26 September 2017

Academic Editor: David Katzenstein

Copyright © 2017 Tatevik Balayan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tatevik Balayan, Hacsi Horvath, and George W. Rutherford, “Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review,” AIDS Research and Treatment, vol. 2017, Article ID 2345617, 9 pages, 2017. https://doi.org/10.1155/2017/2345617.